Seaport Therapeutics, Inc. · NASDAQ:SPTX
Goldman Sachs Group Inc reported a 5.50% stake in Seaport Therapeutics, Inc. (Schedule 13G)
Event May 6, 2026 · Filed May 11, 2026
Goldman Sachs Group Inc reported a 5.50% stake in Seaport Therapeutics, Inc., 2,791,814 shares, as a passive investor on May 6, 2026. Filed May 11, 2026 (Schedule 13G).
- Stake
- 5.50%
- Shares
- 2,791,814
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| THE GOLDMAN SACHS GROUP, INC. | 5.50% | 2,791,814 |
| GOLDMAN SACHS & CO. LLC | 5.50% | 2,791,814 |
Source
Related
- Seaport Therapeutics, Inc.
- Goldman Sachs Group Inc
- Seaport Therapeutics, Inc. shareholders
- Schedule 13G · PureTech Health plc · Aug 14, 2026
- Schedule 13G · Paul Steven M · Aug 5, 2026
- Schedule 13G · Zohar Daphne · Aug 5, 2026
- Form 4 · Hombach Robert J. · Jun 24, 2026
- Schedule 13D · General Atlantic, L.P. · May 11, 2026